Tempest Therapeutics, Inc.
TPST
$10.03
$0.6757.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.75% | -50.54% | -41.88% | -14.18% | 4.57% |
| Total Depreciation and Amortization | -32.45% | 7.27% | 2.10% | -17.15% | -33.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.88% | 26.34% | 53.81% | 80.54% | 79.50% |
| Change in Net Operating Assets | -117.79% | 280.93% | 160.25% | 12.31% | 84.08% |
| Cash from Operations | -45.11% | -29.10% | -20.73% | -5.03% | 16.16% |
| Capital Expenditure | 95.75% | 8.56% | -155.88% | 15.41% | 32.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.75% | 8.56% | -155.88% | 15.41% | 32.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 53.60% | -- |
| Issuance of Common Stock | -26.51% | -16.89% | -18.83% | 3,306.80% | 2,368.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.28% | -35.21% | -31.18% | 1,277.57% | 1,352.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -223.90% | -214.13% | -210.98% | 136.03% | 139.97% |